Advertisement Ipsogen names new president for its US subsidiary - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Ipsogen names new president for its US subsidiary

Ipsogen SA, a molecular diagnostic company, has appointed Susan Hertzberg as the new president of Ipsogen Inc, the wholly owned US subsidiary of the company.

Ipsogen SA has also appointed Ms Hertzberg as its vice president of corporate business development.

Immediately prior to joining Ipsogen, Ms Hertzberg served as general manager of global accounts at Abbott Diagnostics. She has received a MBA from Columbia University, New York.

Vincent Fert, CEO of Ipsogen, said: “We are excited to have Susan at Ipsogen. Her broad commercial experience and deep knowledge of the IVD and laboratory services sectors is a great advantage as we expand our presence in North American and around the world.”